Monday, February 06, 2012

Regional development Norway-Sweden

img-flash-replacement_resizeBBOI is a strategic approach to consolidate the Swedish and Norwegian expertise in marine biotech, a kind of strategic dialogue bridge between sister organisation ''MareNovum' from Sweden and 'MareLife' from Norway.

More operational projects are already underway with: NORDOSTRON, COINCO and our meeting places: Vattenbruks conference, North Atlantic Seafood Conference and more.

Levels of operation:

  • Dialogue bridge: MARINN (between MareNovum and MareLife)
  • Strategic project: BBOI (consolidation of the Swedish and Norwegian marine biotech)
  • Operational projects: NORDOSTRON, new project plans, installed meeting places etc
Mare Life and MareNovum
MareLife has managed to establish itself as a suitable vehicle for expressing the opinions of the Norwegian bio marine sector as well as defining
the major challenges and opportunities to be addressed through R&D and innovation. This has been communicated to the authorities and official recognition has resulted implications for budgeting and the priorities of the grant programs. Among such major issues are: forecasting aquaculture productivity and yields (disease control, biomass measurements etc), mapping and monitoring marine resources and environments to optimize management
regimes, sustainable bio marine production systems (feed resources, energy and environmental friendly systems etc), quality assurance, transparency and
traceability in the seafood value chain to build consumer confidence, building trust and strong brands and strenthening the blue biotech sector, target
ing ingredients and other marine bio active molecules for a wide variety of purposes.

Some selected projects facilitated by MareLife or wherein MareLife has been involved:
“Mackerel Trace” (genetic verification of mackerel stock structures enhancing quality of management and catch regimes and contributing to building
trusted brands ), “ChemBioNet Norway” (linking the generic drug discovery platform of Biotechnology Center of Oslo with the leading marine pharma
companies), entered into pilot projects in the following fields: “Live culture prediction” (fish health, bio banks and biomass measurements), “Micro algae” (feeds, ingredients, pharma, fertilizer, energy etc), “Ocean Box” (remote sensor based ocean environments surveys), “El-Trace/GenVer” (linking electronic traceability with genetic verification of origin of seafood), “Competent capital tool case” (assist the commercialization of ideas, inventions and start ups with potentials), “Reputation management” (communication strategies), “MareLife Storby” (consolidating Norway as a concerted action biomarine cluster), installing a unique cross sector innovation arena within MareLife.

Mare Novum, a collaboration between the region, the University of Gothenburg and the holding company at the University, acts as a gateway between industry and academia and has an extensive network both within Sweden and abroad. The Cluster mediates collaborations between industry and others, e.g. in joint R&D programs, by arranging discussions forums and seminars in relevant topics, and supporting the commercialisation of innovative ideas.

“MARINN” is the working title working title of a Swedish- Norwegian plan aimed at defining and managing a Scandinavian marine biotechnology competence platform, building on the strong research and entrepreneurial spirit within this area. MedCoast Scandinavia and the MareLife counterpart in Sweden, Mare Novum, have been instrumental in these efforts. The MARINN initiative will be linked with the recently Interreg IVA granted project COINCO with the aim to define and develop the Skagerrak/Kattegat region as world leading in selected knowledge based industry fields, where life science targeting the bio marine sector is one of the prioritized areas.


Add this page to your favorite Social Bookmarking websites

Login Form